产品资料

Mouse Anti-Dengue Pan Envelope Protein Antibody

如果您对该产品感兴趣的话,可以
产品名称: Mouse Anti-Dengue Pan Envelope Protein Antibody
产品型号:
产品展商: 其他品牌
产品文档: 无相关文档

简单介绍

Mouse monoclonal antibody specific for Dengue pan envelope protein.


Mouse Anti-Dengue Pan Envelope Protein Antibody  的详细介绍

Mouse Anti-Dengue Pan Envelope Protein Antibody

 

Mouse anti-Dengue pan envelope antibody reacts with envelope protein from Dengue Virus serotypes 1, 2, 3 and 4.

Dengue virus is a member of the flavivirus family, which includes Zika virus, West Nile virus and Japanese Encephalitis virus. Many of the proteins expressed by these viruses are very similar, and serological testing for these viruses can be complicated by problems of cross-reactivity. In this context, the use of highly purified antigens, that are glycosylated and folded as native proteins can be highly important in the development of accurate immunoassays.

With more than one-third of the world’s population living in areas at risk of transmission, dengue infection is a leading cause of illness and death in the tropics and subtropics (ref WHO for Guidelines for Diagnosis, Treatment, Prevention & Control, 2009). Dengue is caused by any one of four related viruses (DENV1-4) which are transmitted by mosquitoes and responsible for infecting as many as 390 million people yearly (Bhatt , et al., 2013).

It is a febrile illness that affects infants, young children and *****s with symptoms appearing 3-14 days after the infective bite. Symptoms range from mild fever, to incapacitating high fever, with severe headache, pain behind the eyes, muscle and joint pain, and rash. There is no vaccine or any specific medicine to treat dengue.

Severe dengue (also known as dengue hemorrhagic fever) is characterized by fever, abdominal pain, persistent vomiting, bleeding and breathing difficulty and is a potentially lethal complication, affecting mainly children. Early clinical diagnosis and careful clinical management by trained physicians and nurses increase survival of patient.

More recently there has been increased interest in the potential of antibody-based immunotherapy as treatment for dengue. The dengue envelope (E) protein is arranged as antiparallel homodimers on the surface of the mature virion, comprising a total of 180 E proteins on the virion surface (Zhang, et al., 2013). It is composed of three domains, DI-DIII, in which DII contains the fusion loop required for viral entry (Modis, et al., 2004). An engineered cross-neutralizing humanized antibody targeting the DENV E domain III has been demonstrated to neutralize DENV in mice, at clinically relevant viral loads or in the presence of enhancing levels of DENV immune sera (Budigi, et al., 2018).

 

References

Bhatt , S. et al., 2013. The global distribution and burden of dengue. Nature, 496(7446), pp. 504-7.

Budigi, Y. et al., 2018. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein. PLoS Negl Trop Dis., 12(2).

Modis, Y., Ogata, S., Clements, D. & Harrison, S. C., 2004. Structure of the dengue virus envelope protein after membrane fusion. Nature, Volume 427, pp. 313-319.

Zhang, X. et al., 2013. Cryo-EM structure of the mature dengue virus at 3.5-A resolution. Nat Struct Mol Biol , Volume 20, pp. 105-110.


Product datasheet
Safety datasheet

产品留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!
相关产品
Adenovirus Type 40
Bordetella Pertussis FHA
Adenovirus Type 40 Hexon Protein
Adenovirus Type 5 Hexon Protein
Astrovirus Antigen (Type 1)
Bordetella Pertussis Toxin (Frozen)
Bordetella Pertussis Toxin (Glycerol)
Bordetella Pertussis Toxin
Chlamydia Trachomatis Antigen
Chikungunya Virus VLP (E1 E2 C protein)
Chikungunya Virus E1 Envelope Protein
Chikungunya Virus E2 Envelope Protein (Human Fc)
Chikungunya Virus E2 Envelope Protein (Mouse Fc)
Cholera Toxin Subunit B
Clostridium Difficile Toxin A
Clostridium Difficile Toxin B
Clostridium Difficile Toxoid A
Clostridium Difficile Toxin A Ribotype 078
Clostridium Difficile Toxin A Ribotype 027
Clostridium Difficile Toxin B Ribotype 027
Clostridium Difficile Toxin B Ribotype 078
Clostridium Difficile Toxoid B
Crimean Congo Hemorrhagic Fever Virus Gn Protein
Crimean Congo Hemorrhagic Fever Virus Nucleoprotein
Cytomegalovirus Glycoprotein B (gB) – Human Fc
Cytomegalovirus gH Pentamer Complex
Cytomegalovirus Glycoprotein B (gB) – Mouse Fc
Cytomegalovirus Purified Antigen
Cytomegalovirus Cell Lysate Antigen
Ebola Virus Envelope Glycoprotein (GP1) (Bundibugyo)
Ebola Virus Envelope Glycoprotein (GP1) (Zaire)
Ebola Virus Secreted Glycoprotein (sGP) (Bundibugyo)
Epstein Barr Virus gp125 – Human Fc
Epstein Barr Virus gp125 – Mouse Fc
Flavivirus NS1 Protein Pack
Goat Anti-Mouse IgG Fc HRP
Goat Anti-Human IgG
Goat Anti-Human IgG (Mouse-Adsorbed)
Dengue Virus NS1 Protein Serotypes 1-4
Dengue Virus Serotype 1 Envelope Protein (Insect Cells)
Dengue Virus Serotype 2 Envelope Protein (HEK293)
Dengue Virus Serotype 2 Envelope Protein (Insect Cells)
Dengue Virus Serotype 3 Envelope Protein (Insect Cells)
Dengue Virus Serotype 4 Envelope Protein (Insect Cells)
Severe Fever with Thrombocytopenia Syndrome Virus Nucleoprotein
Dengue Virus Serotype 3 NS1 Protein
Dengue Virus Serotype 3 VLP
Dengue Virus Serotype 4 Envelope Protein (HEK293)
Dengue Virus Serotype 4 NS1 Protein
Dengue Virus Serotype 4 VLP

沪公网安备 31011202007343号